These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8679155)

  • 1. DNA index, cellular proliferative activity and nucleolar organizer regions in cancers of the larynx.
    Cappiello J; Nicolai P; Antonelli AR; Facchetti F; Cadei M; Cornacchiari A; Grigolato PG
    Eur Arch Otorhinolaryngol; 1995; 252(6):353-8. PubMed ID: 8679155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleolar organizer regions in squamous cell carcinoma of the head and neck.
    Hirsch SM; DuCanto J; Caldarelli DD; Hutchinson JC; Coon JS
    Laryngoscope; 1992 Jan; 102(1):39-44. PubMed ID: 1370566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive analysis of selected diagnostic methods with respect to their usefulness in evaluating the biology of neoplastic cells in patients with laryngeal cancer.
    Golusinski W; Olofsson J; Szmeja Z; Biczysko W; Krygier-Stojałowska A; Kulczyński B
    Eur Arch Otorhinolaryngol; 1999; 256(6):306-11. PubMed ID: 10456281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.
    Ghazizadeh M; Sasaki Y; Araki T; Konishi H; Aihara K
    Am J Clin Pathol; 1997 Apr; 107(4):451-8. PubMed ID: 9124214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferating cell nuclear antigen counts as markers of cell proliferation in head and neck cancer.
    Lörz M; Meyer-Breiting E; Bettinger R
    Eur Arch Otorhinolaryngol; 1994; 251(2):91-4. PubMed ID: 7517683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retrospective analysis of selected tumor markers (p53, PCNA, Ki67; DNA ploidy) and ultrastructure in patients with larynx carcinomas].
    Golusiñski W; Szmeja Z; Olofsson J; Biczysko W; Krygier-Stojałzowska A; Majewski P
    HNO; 1998 Mar; 46(3):233-40. PubMed ID: 9583028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the primary tumour and the metastatic lymph node with or without extracapsular spread by means of argyrophillic nucleolar regions (AgNOR).
    Bilgen C; Sarioglu S; Ceryan K
    Rev Laryngol Otol Rhinol (Bord); 2000; 121(3):155-9. PubMed ID: 11109880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.
    Lipponen PK; Eskelinen MJ
    Br J Cancer; 1992 Jul; 66(1):171-6. PubMed ID: 1353364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometric determination of AgNORs in breast carcinoma. Correlation with flow cytometry and proliferating cell nuclear antigen.
    Bellotti M; Elsner B; Kahn A; Bezodnick L; Pisilli L; Greco P
    Anal Quant Cytol Histol; 1997 Apr; 19(2):139-44. PubMed ID: 9113306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argyrophilic nucleolar organizer regions in breast carcinoma. Correlation with DNA flow cytometry, histopathology, and lymph node status.
    Mourad WA; Erkman-Balis B; Livingston S; Shoukri M; Cox CE; Nicosia SV; Rowlands DT
    Cancer; 1992 Apr; 69(7):1739-44. PubMed ID: 1312892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of cellular proliferation in human prostate by AgNOR, PCNA, and SPF.
    Sakr WA; Sarkar FH; Sreepathi P; Drozdowicz S; Crissman JD
    Prostate; 1993; 22(2):147-54. PubMed ID: 7681206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions.
    Brustmann H; Naudé S
    Gynecol Oncol; 2002 Aug; 86(2):192-9. PubMed ID: 12144828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of AgNOR and Ki-67 antigen as cell kinetic parameters in oral dysplasias and carcinomas.
    Zoeller J; Flentje M; Sinn P; Born IA
    Anal Cell Pathol; 1994 Jul; 7(1):77-88. PubMed ID: 7981138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas.
    Krüger S; Müller H
    Br J Urol; 1995 Apr; 75(4):480-4. PubMed ID: 7788260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
    Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
    Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx.
    Liu M; Lawson G; Delos M; Jamart J; Chatelain B; Remacle M; Marbaix E
    Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):28-34. PubMed ID: 12520353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Correlation with DNA flow cytometric analysis.
    Kawai T; Suzuki M; Kono S; Shinomiya N; Rokutanda M; Takagi K; Ogata T; Tamai S
    Cancer; 1994 Nov; 74(9):2468-75. PubMed ID: 7923002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of proliferation-associated markers Ag-NOR and Ki-67 does not contribute to the prediction of lymph node metastases in squamous cell carcinoma of the vulva.
    Emanuels AG; Burger MP; Hollema H; Koudstaal J
    Hum Pathol; 1996 Aug; 27(8):807-11. PubMed ID: 8760014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome.
    Delahunt B; Bethwaite PB; Thornton A; Ribas JL
    Cancer; 1995 Jun; 75(11):2714-9. PubMed ID: 7743475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx.
    Zidar N; Gale N; Cör A; Kambic V
    J Laryngol Otol; 1996 May; 110(5):440-5. PubMed ID: 8762312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.